Pacific Biosciences of California Inc
PACB1.390USD
+0.060+4.51%
收盤 08/04, 16:00（美東）報價延遲15分鐘
417.06M總市值
虧損本益比TTM
關於 Pacific Biosciences of California Inc 公司
Pacific Biosciences of California, Inc. 是一家生命科學技術公司。該公司致力於設計、開發和製造先進的測序解決方案，幫助科學家和臨牀研究人員解決複雜的遺傳問題。該公司正在開發的產品和技術源自兩項差異化的核心技術，包括其 HiFi 長讀測序技術和結合測序 (SBB) 短讀測序技術。該公司的產品爲一系列應用提供解決方案，包括人類遺傳學、植物和動物科學、傳染病和微生物學、腫瘤學和其他新興應用。該公司開發了基於單分子實時技術的 HiFi 長讀測序，可準確檢測單個 DNA 分子的核苷酸序列和表觀遺傳狀態。其 Revio、Sequel、Sequel II 和 Sequel IIe 儀器可實時進行、監測和分析單分子生化反應。
公司簡介
公司代碼PACB
公司名稱Pacific Biosciences of California Inc
上市日期Oct 27, 2010
CEOMr. Christian O. Henry
員工數量575
證券類型Ordinary Share
年結日Oct 27
公司地址1305 O'brien Drive
城市MENLO PARK
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94025
電話16505218000
網址https://www.pacb.com/
公司代碼PACB
上市日期Oct 27, 2010
CEOMr. Christian O. Henry
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jim R. Gibson
Mr. Jim R. Gibson
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
地區USD
名稱
營收
佔比
North America
16.30M
43.88%
Asia Pacific
11.61M
31.25%
Europe (including the Middle East and Africa)
9.24M
24.87%
業務
地區
業務USD
名稱
營收
佔比
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
股東統計
更新時間: 6月13日 週五
更新時間: 6月13日 週五
持股股東
股東類型
持股股東
持股股東
佔比
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
持股股東
持股股東
佔比
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
股東類型
持股股東
佔比
Investment Advisor
46.28%
Investment Advisor/Hedge Fund
11.14%
Holding Company
6.82%
Research Firm
2.18%
Hedge Fund
2.07%
Individual Investor
1.18%
Corporation
1.17%
Bank and Trust
0.50%
Pension Fund
0.26%
Other
28.40%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
600
215.28M
71.74%
-113.79M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
2023Q2
639
248.61M
99.68%
-37.06M
2023Q1
649
249.45M
101.17%
-6.40M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
ARK Investment Management LLC
36.48M
12.16%
+434.08K
+1.20%
Mar 31, 2025
Madrone Advisors, LLC
23.39M
7.8%
--
--
Mar 31, 2025
SoftBank Group Corp
20.45M
6.82%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.44M
6.81%
-1.17M
-5.42%
Mar 31, 2025
The Vanguard Group, Inc.
16.21M
5.4%
+1.04M
+6.83%
Mar 31, 2025
Edmond de Rothschild Asset Management (France) S.A.
21.86M
7.28%
+508.70K
+2.38%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
9.57M
3.19%
-613.17K
-6.02%
Mar 31, 2025
State Street Global Advisors (US)
6.38M
2.13%
-47.38K
-0.74%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.32M
2.11%
+54.32K
+0.87%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
4.89M
1.63%
-8.23K
-0.17%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ARK Genomic Revolution ETF
1.34%
iShares Genomics Immunology and Healthcare ETF
0.75%
Invesco NASDAQ Future Gen 200 ETF
0.58%
Global X Genomics & Biotechnology ETF
0.42%
ARK Innovation ETF
0.41%
WisdomTree BioRevolution Fund
0.31%
AXS Green Alpha ETF
0.27%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
查看更多
ARK Genomic Revolution ETF
佔比1.34%
iShares Genomics Immunology and Healthcare ETF
佔比0.75%
Invesco NASDAQ Future Gen 200 ETF
佔比0.58%
Global X Genomics & Biotechnology ETF
佔比0.42%
ARK Innovation ETF
佔比0.41%
WisdomTree BioRevolution Fund
佔比0.31%
AXS Green Alpha ETF
佔比0.27%
Invesco Nasdaq Biotechnology ETF
佔比0.04%
ProShares Ultra Nasdaq Biotechnology
佔比0.04%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.04%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
